Sandoz Fights $39M Loss In Suit Over Eyelash Growth Serum
Novartis' generic-drug making arm wants another shot at persuading a federal jury in Colorado to wipe out a patent covering a drug developed by researchers at Duke University to grow eyelashes,...To view the full article, register now.
Already a subscriber? Click here to view full article